FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer

被引:0
作者
F Bertolini
N Malavasi
L Scarabelli
F Fiocchi
B Bagni
C Del Giovane
G Colucci
G E Gerunda
R Depenni
S Zironi
A Fontana
E Pettorelli
G Luppi
P F Conte
机构
[1] Oncology,Haematology and Respiratory Diseases Department
[2] University Hospital of Modena,Nuclear Medicine Division
[3] Radiology Institute,Multiorgan Transplantation Division
[4] University Hospital of Modena,undefined
[5] University Hospital of Modena,undefined
[6] General Surgery,undefined
[7] Vignola Hospital,undefined
[8] Azienda USL Modena,undefined
[9] University Hospital of Modena,undefined
来源
British Journal of Cancer | 2011年 / 104卷
关键词
bevacizumab; liver metastases; colorectal cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1079 / 1084
页数:5
相关论文
共 259 条
[1]  
Adam R(2004)Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg 240 644-657
[2]  
Delvart V(2006)Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 4 3939-3945
[3]  
Pascal G(2008)Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases J Clin Oncol 26 5344-5351
[4]  
Valeanu A(2009)Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer J Clin Oncol 27 663-671
[5]  
Castaing D(2006)Neoadjuvant treatment of unresectable liver metastases from colorectal cancer Clin Colorectal Cancer 5 405-412
[6]  
Azoulay D(2009)Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases JAMA 302 2338-2344
[7]  
Giacchetti S(2007)Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest J Clin Oncol 25 1670-1676
[8]  
Paule B(2005)Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates Ann Oncol 16 1311-1319
[9]  
Kunstlinger F(2010)Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial Lancet Oncol 11 38-47
[10]  
Ghémard O(2008)Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer J Clin Oncol 26 1830-1835